Indiana University (IU) Melvin and Bren Simon Cancer Center advances the understanding, prevention and treatment of cancer throughout Indiana and the world with patient-centered care, acceleration of promising science and collaborative educational programs. Established in 1992 as the IU Cancer Center, it has been an NCI-designated Cancer Center since 1999 and is the only center with such distinction in Indiana that provides patient care. It changed its name in 2006 to reflect the philanthropic support of the Melvin and Bren Simon family.
There are about 38,000 outpatient visits and 4,100 inpatient visits to the IU Simon Cancer Center each year by patients seeking comprehensive, multidisciplinary care for a broad range of cancer and blood-related illnesses in both adults and children. With its physicians leading about 300 clinical trials for pediatric and adult cancers, IU Simon Cancer Center offers patients diagnostic, treatment and prevention options not available elsewhere.
IU Simon Cancer received $11.5 million in NCI funding and a total of $32.5 million in other NIH funding for fiscal year 2006. Over 200 investigators conduct research in the areas of experimental and development therapeutics, breast cancer, cancer control, as well as hematopoiesis, microenvironment and immunology. The IU Simon Cancer Center’s Translational Research Acceleration Collaboration (ITRAC) is the internal planning and funding process which has recently been implemented to speed the development of new cancer diagnostics and therapies from the laboratory to the bedside. Molecular and environmental carcinogenesis is one research area currently in development at the center.
Physician and basic research scientists teach nearly 2,000 students, residents, and fellows each year at the IU Simon Cancer Center. Educational programs sponsored by faculty at this center include the Summer Research Program dedicated to engaging students from underserved populations in biomedical and behavioral science careers, the Cancer Biology Training Program for pre-doctoral and post-doctoral students who wish to pursue a career in cancer research and the Behavioral Oncology Program for post-graduate careers in behavioral cancer control research.
In Fall 2008, the IU Simon Cancer Center, in partnership with Clarian Health and IU School of Medicine, will complete a $150 million, 405,000-square-foot integrated outpatient and inpatient center with an environment that fosters both a holistic approach to care and collaboration between basic research and physician scientists. With the completion of Research III in the first quarter of 2009, it will add another 125,000 square feet of laboratory space to its existing 200,000 square feet of dedicated cancer research space.
Find a doctor
http://www.cancer.iu.edu/patients/find_doctor/
Make an appointment
Patients and referring physicians can schedule an appointment with most IU Simon Cancer Center physicians. Patients can self-refer to all of our clinical program exept the Gynecologic Oncology Program, which requires a physician referral.To make an appointment at the IU Simon Cancer Center or for more information about available treatment options and clinical trials, call (317) 944-0920 or 1-888-600-4822 from 8 a.m. to 5 p.m. Monday through Friday. If you are not calling during these times, please leave a message and your phone call will be returned. Patients may also contact the appropriate clinical program directly. As we offer multidisciplinary care, it is important that we speak to all new patients by telephone to assure a productive and efficient first appointment.
You may also contact IU Health On-Call for physician referral at (317) 916-3525 or (800) 265-3220 from 8 a.m. to 5 p.m. Monday – Friday.
Referring physicians should contact the IU Health IMACS referral system as instructed in the Refer a Patient section.
For more information about a specific cancer, support services and clinical trials available nationally, see the About Cancer section or contact the NCI’s Cancer Information Service at 1-800-422-6237.
*Source: National Cancer Institute; Indiana University Melvin and Bren Simon Cancer Center
http://www.cancer.iu.edu/